What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock
Key PointsThe CEO sold 15,978 shares at a weighted-average price of $623.93 over two trading days ending Aug. 24, 2026.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.